Global Nuclear Drug for Therapeutic Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the Nuclear Drug for Therapeutic market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Nuclear Drug for Therapeutic business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Nuclear Drug for Therapeutic market by type, application, key companies and key regions.
This study considers the Nuclear Drug for Therapeutic value generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Radium-223
Lutetium-177
Iodine-131
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Thyroid
Bone Metastasis
Lymphoma
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bayer
Progenics Pharmaceuticals
Novartis
Dongcheng
Q BioMed
China Isotope & Radiation
Lantheus
Curium Pharmaceuticals
Spectrum Pharmaceuticals
Jubilant DraxImage
International Isotopes
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Nuclear Drug for Therapeutic market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Nuclear Drug for Therapeutic market by identifying its various subsegments.
Focuses on the key global Nuclear Drug for Therapeutic players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nuclear Drug for Therapeutic with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Nuclear Drug for Therapeutic submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nuclear Drug for Therapeutic Market Size 2015-2025
2.1.2 Nuclear Drug for Therapeutic Market Size CAGR by Region
2.2 Nuclear Drug for Therapeutic Segment by Type
2.2.1 Radium-223
2.2.2 Radium-223
2.2.3 Iodine-131
2.2.4 Other
2.3 Nuclear Drug for Therapeutic Market Size by Type
2.3.1 Global Nuclear Drug for Therapeutic Market Size Market Share by Type (2015-2020)
2.3.2 Global Nuclear Drug for Therapeutic Market Size Growth Rate by Type (2015-2020)
2.4 Nuclear Drug for Therapeutic Segment by Application
2.4.1 Thyroid
2.4.2 Bone Metastasis
2.4.3 Lymphoma
2.4.4 Other
2.5 Nuclear Drug for Therapeutic Market Size by Application
2.5.1 Global Nuclear Drug for Therapeutic Market Size Market Share by Application (2015-2020)
2.5.2 Global Nuclear Drug for Therapeutic Market Size Growth Rate by Application (2015-2020)
3 Global Nuclear Drug for Therapeutic by Players
3.1 Global Nuclear Drug for Therapeutic Market Size Market Share by Players
3.1.1 Global Nuclear Drug for Therapeutic Market Size by Players (2018-2020)
3.1.2 Global Nuclear Drug for Therapeutic Market Size Market Share by Players (2018-2020)
3.2 Global Nuclear Drug for Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nuclear Drug for Therapeutic by Regions
4.1 Nuclear Drug for Therapeutic Market Size by Regions
4.2 Americas Nuclear Drug for Therapeutic Market Size Growth
4.3 APAC Nuclear Drug for Therapeutic Market Size Growth
4.4 Europe Nuclear Drug for Therapeutic Market Size Growth
4.5 Middle East & Africa Nuclear Drug for Therapeutic Market Size Growth
5 Americas
5.1 Americas Nuclear Drug for Therapeutic Market Size by Countries
5.2 Americas Nuclear Drug for Therapeutic Market Size by Type
5.3 Americas Nuclear Drug for Therapeutic Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Nuclear Drug for Therapeutic Market Size by Regions
6.2 APAC Nuclear Drug for Therapeutic Market Size by Type
6.3 APAC Nuclear Drug for Therapeutic Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Nuclear Drug for Therapeutic by Countries
7.2 Europe Nuclear Drug for Therapeutic Market Size by Type
7.3 Europe Nuclear Drug for Therapeutic Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Nuclear Drug for Therapeutic by Countries
8.2 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type
8.3 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Nuclear Drug for Therapeutic Market Forecast
10.1 Global Nuclear Drug for Therapeutic Market Size Forecast (2021-2025)
10.2 Global Nuclear Drug for Therapeutic Forecast by Regions
10.2.1 Global Nuclear Drug for Therapeutic Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Nuclear Drug for Therapeutic Forecast by Type
10.8 Global Nuclear Drug for Therapeutic Forecast by Application
11 Key Players Analysis
11.1 Bayer
11.1.1 Company Details
11.1.2 Nuclear Drug for Therapeutic Product Offered
11.1.3 Bayer Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Bayer News
11.2 Progenics Pharmaceuticals
11.2.1 Company Details
11.2.2 Nuclear Drug for Therapeutic Product Offered
11.2.3 Progenics Pharmaceuticals Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Progenics Pharmaceuticals News
11.3 Novartis
11.3.1 Company Details
11.3.2 Nuclear Drug for Therapeutic Product Offered
11.3.3 Novartis Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Novartis News
11.4 Dongcheng
11.4.1 Company Details
11.4.2 Nuclear Drug for Therapeutic Product Offered
11.4.3 Dongcheng Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Dongcheng News
11.5 Q BioMed
11.5.1 Company Details
11.5.2 Nuclear Drug for Therapeutic Product Offered
11.5.3 Q BioMed Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Q BioMed News
11.6 China Isotope & Radiation
11.6.1 Company Details
11.6.2 Nuclear Drug for Therapeutic Product Offered
11.6.3 China Isotope & Radiation Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 China Isotope & Radiation News
11.7 Lantheus
11.7.1 Company Details
11.7.2 Nuclear Drug for Therapeutic Product Offered
11.7.3 Lantheus Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Lantheus News
11.8 Curium Pharmaceuticals
11.8.1 Company Details
11.8.2 Nuclear Drug for Therapeutic Product Offered
11.8.3 Curium Pharmaceuticals Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Curium Pharmaceuticals News
11.9 Spectrum Pharmaceuticals
11.9.1 Company Details
11.9.2 Nuclear Drug for Therapeutic Product Offered
11.9.3 Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Spectrum Pharmaceuticals News
11.10 Jubilant DraxImage
11.10.1 Company Details
11.10.2 Nuclear Drug for Therapeutic Product Offered
11.10.3 Jubilant DraxImage Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Jubilant DraxImage News
11.11 International Isotopes
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Nuclear Drug for Therapeutic Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Radium-223
Table 5. Major Players of Lutetium-177
Table 6. Major Players of Iodine-131
Table 7. Major Players of Other
Table 8. Nuclear Drug for Therapeutic Market Size by Type (2014-2019) ($ Millions)
Table 9. Global Nuclear Drug for Therapeutic Market Size Market Share by Type (2015-2020)
Table 10. Global Nuclear Drug for Therapeutic Market Size by Application (2015-2020) ($ Millions)
Table 11. Global Nuclear Drug for Therapeutic Market Size Market Share by Application (2015-2020)
Table 12. Global Nuclear Drug for Therapeutic Revenue by Players (2018-2020) ($ Millions)
Table 13. Global Nuclear Drug for Therapeutic Revenue Market Share by Players (2018-2020)
Table 14. Global Nuclear Drug for Therapeutic Key Players Head office and Products Offered
Table 15. Nuclear Drug for Therapeutic Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Nuclear Drug for Therapeutic Market Size by Regions 2015-2020 ($ Millions)
Table 19. Global Nuclear Drug for Therapeutic Market Size Market Share by Regions 2015-2020
Table 20. Americas Nuclear Drug for Therapeutic Market Size by Countries (2015-2020) ($ Millions)
Table 21. Americas Nuclear Drug for Therapeutic Market Size Market Share by Countries (2015-2020)
Table 22. Americas Nuclear Drug for Therapeutic Market Size by Type (2015-2020) ($ Millions)
Table 23. Americas Nuclear Drug for Therapeutic Market Size Market Share by Type (2015-2020)
Table 24. Americas Nuclear Drug for Therapeutic Market Size by Application (2015-2020) ($ Millions)
Table 25. Americas Nuclear Drug for Therapeutic Market Size Market Share by Application (2015-2020)
Table 26. APAC Nuclear Drug for Therapeutic Market Size by Regions (2015-2020) ($ Millions)
Table 27. APAC Nuclear Drug for Therapeutic Market Size Market Share by Regions (2015-2020)
Table 28. APAC Nuclear Drug for Therapeutic Market Size by Type (2015-2020) ($ Millions)
Table 29. APAC Nuclear Drug for Therapeutic Market Size Market Share by Type (2015-2020)
Table 30. APAC Nuclear Drug for Therapeutic Market Size by Application (2015-2020) ($ Millions)
Table 31. APAC Nuclear Drug for Therapeutic Market Size Market Share by Application (2015-2020)
Table 32. Europe Nuclear Drug for Therapeutic Market Size by Countries (2015-2020) ($ Millions)
Table 33. Europe Nuclear Drug for Therapeutic Market Size Market Share by Countries (2015-2020)
Table 34. Europe Nuclear Drug for Therapeutic Market Size by Type (2015-2020) ($ Millions)
Table 35. Europe Nuclear Drug for Therapeutic Market Size Market Share by Type (2015-2020)
Table 36. Europe Nuclear Drug for Therapeutic Market Size by Application (2015-2020) ($ Millions)
Table 37. Europe Nuclear Drug for Therapeutic Market Size Market Share by Application (2015-2020)
Table 38. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Countries (2015-2020) ($ Millions)
Table 39. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type (2015-2020) ($ Millions)
Table 41. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Type (2015-2020)
Table 42. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application (2015-2020) ($ Millions)
Table 43. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Application (2015-2020)
Table 44. Key and Potential Regions of Nuclear Drug for Therapeutic
Table 45. Key Application and Potential Industries of Nuclear Drug for Therapeutic
Table 46. Key Challenges of Nuclear Drug for Therapeutic
Table 47. Key Trends of Nuclear Drug for Therapeutic
Table 48. Global Nuclear Drug for Therapeutic Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 49. Global Nuclear Drug for Therapeutic Market Size Market Share Forecast by Regions
Table 50. Global Nuclear Drug for Therapeutic Market Size Forecast by Type (2021-2025) ($ Millions)
Table 51. Global Nuclear Drug for Therapeutic Market Size Market Share Forecast by Type (2021-2025)
Table 52. Global Nuclear Drug for Therapeutic Market Size Forecast by Application (2021-2025) ($ Millions)
Table 53. Global Nuclear Drug for Therapeutic Market Size Market Share Forecast by Application (2021-2025)
Table 54. Bayer Details, Company Total Revenue (in $ million), Head Office, Nuclear Drug for Therapeutic Major Market Areas and Its Competitors
Table 55. Bayer Nuclear Drug for Therapeutic Product Offered
Table 56. Bayer Nuclear Drug for Therapeutic Revenue and Gross Margin (2018-2020E)
Table 57. Bayer Main Business
Table 58. Bayer Latest Developments
Table 59. Progenics Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Nuclear Drug for Therapeutic Major Market Areas and Its Competitors
Table 60. Progenics Pharmaceuticals Nuclear Drug for Therapeutic Product Offered
Table 61. Progenics Pharmaceuticals Main Business
Table 62. Progenics Pharmaceuticals Nuclear Drug for Therapeutic Revenue and Gross Margin (2018-2020E)
Table 63. Progenics Pharmaceuticals Latest Developments
Table 64. Novartis Details, Company Total Revenue (in $ million), Head Office, Nuclear Drug for Therapeutic Major Market Areas and Its Competitors
Table 65. Novartis Nuclear Drug for Therapeutic Product Offered
Table 66. Novartis Main Business
Table 67. Novartis Nuclear Drug for Therapeutic Revenue and Gross Margin (2018-2020E)
Table 68. Novartis Latest Developments
Table 69. Dongcheng Details, Company Total Revenue (in $ million), Head Office, Nuclear Drug for Therapeutic Major Market Areas and Its Competitors
Table 70. Dongcheng Nuclear Drug for Therapeutic Product Offered
Table 71. Dongcheng Main Business
Table 72. Dongcheng Nuclear Drug for Therapeutic Revenue and Gross Margin (2018-2020E)
Table 73. Dongcheng Latest Developments
Table 74. Q BioMed Details, Company Total Revenue (in $ million), Head Office, Nuclear Drug for Therapeutic Major Market Areas and Its Competitors
Table 75. Q BioMed Nuclear Drug for Therapeutic Product Offered
Table 76. Q BioMed Main Business
Table 77. Q BioMed Nuclear Drug for Therapeutic Revenue and Gross Margin (2018-2020E)
Table 78. Q BioMed Latest Developments
Table 79. China Isotope & Radiation Details, Company Total Revenue (in $ million), Head Office, Nuclear Drug for Therapeutic Major Market Areas and Its Competitors
Table 80. China Isotope & Radiation Nuclear Drug for Therapeutic Product Offered
Table 81. China Isotope & Radiation Main Business
Table 82. China Isotope & Radiation Nuclear Drug for Therapeutic Revenue and Gross Margin (2018-2020E)
Table 83. China Isotope & Radiation Latest Developments
Table 84. Lantheus Details, Company Total Revenue (in $ million), Head Office, Nuclear Drug for Therapeutic Major Market Areas and Its Competitors
Table 85. Lantheus Nuclear Drug for Therapeutic Product Offered
Table 86. Lantheus Main Business
Table 87. Lantheus Nuclear Drug for Therapeutic Revenue and Gross Margin (2018-2020E)
Table 88. Lantheus Latest Developments
Table 89. Curium Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Nuclear Drug for Therapeutic Major Market Areas and Its Competitors
Table 90. Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Offered
Table 91. Curium Pharmaceuticals Main Business
Table 92. Curium Pharmaceuticals Nuclear Drug for Therapeutic Revenue and Gross Margin (2018-2020E)
Table 93. Curium Pharmaceuticals Latest Developments
Table 94. Spectrum Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Nuclear Drug for Therapeutic Major Market Areas and Its Competitors
Table 95. Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Product Offered
Table 96. Spectrum Pharmaceuticals Main Business
Table 97. Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Revenue and Gross Margin (2018-2020E)
Table 98. Spectrum Pharmaceuticals Latest Developments
Table 99. Jubilant DraxImage Details, Company Total Revenue (in $ million), Head Office, Nuclear Drug for Therapeutic Major Market Areas and Its Competitors
Table 100. Jubilant DraxImage Nuclear Drug for Therapeutic Product Offered
Table 101. Jubilant DraxImage Main Business
Table 102. Jubilant DraxImage Nuclear Drug for Therapeutic Revenue and Gross Margin (2018-2020E)
Table 103. Jubilant DraxImage Latest Developments
Table 104. International Isotopes Details, Company Total Revenue (in $ million), Head Office, Nuclear Drug for Therapeutic Major Market Areas and Its Competitors
List of Figures
Figure 1. Nuclear Drug for Therapeutic Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Nuclear Drug for Therapeutic Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Nuclear Drug for Therapeutic Market Size Market Share by Type (2015-2020)
Figure 5. Global Radium-223 Market Size Growth Rate
Figure 6. Global Lutetium-177 Market Size Growth Rate
Figure 7. Global Iodine-131 Market Size Growth Rate
Figure 8. Global Other Market Size Growth Rate
Figure 9. Nuclear Drug for Therapeutic in Thyroid
Figure 10. Global Nuclear Drug for Therapeutic Market: Thyroid (2015-2020) ($ Millions)
Figure 11. Nuclear Drug for Therapeutic in Bone Metastasis
Figure 12. Global Nuclear Drug for Therapeutic Market: Bone Metastasis (2015-2020) ($ Millions)
Figure 13. Nuclear Drug for Therapeutic in Lymphoma
Figure 14. Global Nuclear Drug for Therapeutic Market: Lymphoma (2015-2020) ($ Millions)
Figure 15. Global Lymphoma YoY Growth ($ Millions)
Figure 16. Nuclear Drug for Therapeutic in Other
Figure 17. Global Nuclear Drug for Therapeutic Market: Other (2015-2020) ($ Millions)
Figure 18. Global Other YoY Growth ($ Millions)
Figure 19. Global Nuclear Drug for Therapeutic Market Size Market Share by Application in 2019
Figure 20. Global Nuclear Drug for Therapeutic Market Size Market Share by Regions 2015-2020
Figure 21. Americas Nuclear Drug for Therapeutic Market Size 2015-2020 ($ Millions)
Figure 22. APAC Nuclear Drug for Therapeutic Market Size 2015-2020 ($ Millions)
Figure 23. Europe Nuclear Drug for Therapeutic Market Size 2015-2020 ($ Millions)
Figure 24. Middle East & Africa Nuclear Drug for Therapeutic Market Size 2015-2020 ($ Millions)
Figure 25. Americas Nuclear Drug for Therapeutic Market Size Market Share by Countries in 2019
Figure 26. Americas Nuclear Drug for Therapeutic Market Size Market Share by Type in 2019
Figure 27. Americas Nuclear Drug for Therapeutic Market Size Market Share by Application in 2019
Figure 28. United States Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 29. Canada Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 30. Mexico Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 31. APAC Nuclear Drug for Therapeutic Market Size Market Share by Regions in 2019
Figure 32. APAC Nuclear Drug for Therapeutic Market Size Market Share by Type in 2019
Figure 33. APAC Nuclear Drug for Therapeutic Market Size Market Share by Application in 2019
Figure 34. China Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 35. Japan Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 36. Korea Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 37. Southeast Asia Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 38. India Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 39. Australia Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 40. Europe Nuclear Drug for Therapeutic Market Size Market Share by Countries in 2019
Figure 41. Europe Nuclear Drug for Therapeutic Market Size Market Share by Type in 2019
Figure 42. Europe Nuclear Drug for Therapeutic Market Size Market Share by Application in 2019
Figure 43. Germany Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 44. France Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 45. UK Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 46. Italy Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 47. Russia Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 48. Spain Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 49. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Countries in 2019
Figure 50. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Type in 2019
Figure 51. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Application in 2019
Figure 52. Egypt Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 53. South Africa Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 54. Israel Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 55. Turkey Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 56. GCC Countries Nuclear Drug for Therapeutic Market Size Growth 2015-2020 ($ Millions)
Figure 57. Global Nuclear Drug for Therapeutic arket Size Forecast (2021-2025) ($ Millions)
Figure 58. Americas Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 59. APAC Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 60. Europe Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 61. Middle East & Africa Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 62. United States Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 63. Canada Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 64. Mexico Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 65. Brazil Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 66. China Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 67. Japan Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 68. Korea Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 69. Southeast Asia Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 70. India Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 71. Australia Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 72. Germany Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 73. France Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 74. UK Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 75. Italy Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 76. Russia Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 77. Spain Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 78. Egypt Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 79. South Africa Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 80. Israel Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 81. Turkey Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Figure 82. GCC Countries Nuclear Drug for Therapeutic Market Size 2021-2025 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets